Skip to content Skip to sidebar Skip to footer

Major policy change for anaphylaxis care

Hospital patients with anaphylaxis will have direct access to their adrenaline injector as part…

Hospital patients with anaphylaxis will have direct access to their adrenaline injector as part of Australia’s first clinical care standard for the condition.

The Australian Commission on Safety and Quality on Healthcare (ACSQH) released the new guidelines which emphasise early treatment and continuity of care.

ACSQHC clinical lead, Associate Professor Amanda Walker, said that the key takeaway for nurses was to “spot early and act promptly”.

“We know that from a study of eight Australian hospital emergency departments that one quarter of patients with reactions that were consistent with anaphylaxis were not given adrenaline,” Walker told Nursing Review.

"Sometimes in hospital or in emergency people may hesitate and give antihistamine or corticosteroids.

“The first important message of the clinical care standard is if you’re thinking anaphylaxis, give intramuscular adrenaline as the first line of treatment.”

An estimated 1 in 5 Australians currently live with allergies, and up to 20 people die each year from anaphylaxis.

In the five years to 2019-20, the number of people admitted to emergency with an anaphylactic reaction rose by 51 per cent.

Allowing patients to hold onto their own injectors while in hospital will help to avoid potentially fatal delays, said Walker.

"Traditionally we ask patients' family members to take all their meds home, or we lock them in the bedside drawer.

“Because it is such a time sensitive, critical issue, and anaphylaxis is such a scary life-threatening experience, we’re making sure that it’s safe for patients to manage it themselves.”

Victoria introduced a similar policy in 2019 after a 13-year-old boy died in hospital after an anaphylactic episode.

In NSW, the Chief Nursing Officer has endorsed the change which is set to be rolled out with the standard across the country.

Nurses who may be hesitant to allow people to take hold of their own treatment should remember that the benefits dramatically outweigh the risks, Walker said.

"I think for people who are used to having control of medications, it's hard to feel that there's something out there that's outside your control," said Walker.

"We're often nervous about adrenaline because it's most often used in intensive care and the operating theatre when people are critically unwell or when they've had a cardiac arrest.

"But intramuscular adrenaline in a person with anaphylaxis is life-saving and the risks of overcalling it are minimal."

In partnership with peak health bodies, the National Allergy Strategy has also launched new guidelines for childcare centres that target staff education and increased incident reporting.

While it has not been recommended for children, allowing patients and carers to carry their own adrenaline supply will help to offer a “safety net” for people, said Walker.

Nationally consistent safety plans

Another significant change recommends that patients suffering from anaphylaxis be discharged with an action plan tailored to their needs.

Developed by the Australasian Society of Clinical Immunology and Allergy, the ASCIA plans are designed to assist health professionals to help their patients better manage their allergies.

Walker said that raising awareness around the plans will also help nurses in different departments and health settings identify ways to support a patient with anaphylaxis.   

“​​It is more targeted in the emergency department because they're so focused on assessment and discharge and making sure people are safe to go home,” she said.

“We want to make sure that whether you're in a small multipurpose service in regional or remote New South Wales, or you're in one of the big hospitals in the city, that people get the same standard of care.”

Leave a comment